PDF herunterladen
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2022; 09(03): 192-194
DOI: 10.1055/s-0042-1744402
Case Report

Management of a Patient with Bombay Blood Group and Chronic Liver Disease with Subdural Hematoma

Siddharth Chavali 
1   Institute of Neurosciences, AIG Hospitals, Gachibowli, Hyderabad, Telangana, India
,
Subodh Raju
1   Institute of Neurosciences, AIG Hospitals, Gachibowli, Hyderabad, Telangana, India
,
Suresh Kanasani
1   Institute of Neurosciences, AIG Hospitals, Gachibowli, Hyderabad, Telangana, India
,
Abhirama C. Gabbita
1   Institute of Neurosciences, AIG Hospitals, Gachibowli, Hyderabad, Telangana, India
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints

Abstract

The Bombay blood group is an extremely rare entity within the conventional ABO blood grouping system. End-stage liver disease also presents with myriad disorders of coagulation due to impaired synthesis and dysfunction of clotting factors, which predisposes patients to spontaneous and life-threatening episodes of bleeding. We report a patient with Bombay blood group and end-stage liver disease who presented to our hospital with a spontaneous subdural hematoma. Although conventional parameters of coagulation in this patient were abnormal, we were able to safely defer product transfusion because his thromboelastography (TEG) report was within acceptable ranges. In this article, we discuss our strategy for optimization of extremely limited blood resources in this scenario and perioperative strategies for the management of coagulation anomalies in patients with liver dysfunction.

Keywords

Bombay blood group - cirrhotic liver disease - subdural hematoma


Publikationsverlauf

Artikel online veröffentlicht:
07. Juni 2022

© 2022. Indian Society of Neuroanaesthesiology and Critical Care. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Oriol R, Candelier JJ, Mollicone R. Molecular genetics of H. Vox Sang 2000; 78 (Suppl 2): 105-108
    PubMedGoogle Scholar
  • 2 Soriano G, RomRomr JJ, Mollicone R. Molecular genetics of H. Vox Sang. 2000;7dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2012; 55 (06) 19229225
    PubMedGoogle Scholar
  • 3 Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002; 22 (01) 83-96
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 4 Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin 2005; 21 (03) 563-587
    CrossrefPubMedGoogle Scholar
  • 5 Bhende YM, Deshpande CK, Bhatia HM. et al. A “new” blood group character related to the ABO system. Lancet 1952; 1 (6714): 903-904
    PubMedGoogle Scholar
  • 6 Cooling LLW, Kelly K, Barton J, Hwang D, Koerner TAW, Olson JD. Determinants of ABH expression on human blood platelets. Blood 2005; 105 (08) 3356-3364
    CrossrefPubMedGoogle Scholar
  • 7 Kumar M, Ahmad J, Maiwall R. et al. Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial. Hepatology 2020; 71 (01) 235-246
    CrossrefPubMedGoogle Scholar